Market Overview

Benzinga's Top #PreMarket Losers


Regado Biosciences (NASDAQ: RGDO) dropped 42.31% to $3.90 in pre-market trading following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform.

BIND Therapeutics (NASDAQ: BIND) shares declined 12.66% to $11.25 in pre-market trading after the company reported the closing of collaboration deal with Amgen (NASDAQ: AMGN).

Real Goods Solar (NASDAQ: RGSE) fell 4.83% to $2.76 in pre-market trading as the company priced 2.92 million units at $2.40 per unit.

SYNNEX (NYSE: SNX) dipped 1.28% to $72.98 in pre-market trading after the company issued a downbeat outlook for the third quarter. It expected adjusted earnings of $1.45 to $1.50 per share on revenue of $3.3 billion to $3.4 billion. Analysts were projecting earnings of $1.53 per share on revenue of $3.29 billion.

Posted-In: Premarket MoversNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (AMGN + BIND)

View Comments and Join the Discussion!

UPDATE: NQ Mobile Offers Status Update on '13 Audit, Reports Changes to Board

Benzinga's Top #PreMarket Gainers